In RUNX1::RUNX1T1 AML patients, KIT was the most frequently mutated gene (81 patients, 46%), followed by ASXL2 (32 patients, 17%) and ASXL1 (28 patients, 16%). The gene discussed is KIT; the disease is acute myeloid leukemia.